Britons paying privately for obesity drugs are increasingly choosing Eli Lilly's Mounjaro over Novo Nordisk's Wegovy, online pharmacies say, in a sign the U.S. drugmaker is gaining ground on its ...
With several of these drugs going off patent in the next few years, OneSource is poised to see big growth in the generic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback